insights_auto
Why is GXE up 2.98%?
Dive Deeperchevron_right
GXE:ETR
Lakefront Biotherapeutics NV
€26.92
arrow_upward
+2.98%(+0.78) 1D
Oct 15, 5:05:47 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GXE...
Open
€26.06
High
€26.96
Low
€26.06
Mkt. cap
1.77B
Avg. vol.
602.00
Volume
1.73K
P/E ratio
2.98
52-wk high
€30.02
52-wk low
€22.84
EPS
€9.05
No. of employees
196
Open
€26.06
High
€26.96
Low
€26.06
Mkt. cap
1.77B
Avg. vol.
602.00
Volume
1.73K
P/E ratio
2.98
52-wk high
€30.02
52-wk low
€22.84
EPS
€9.05
No. of employees
196
News stories
From web sources and news partners
FOREX.com
·
51 minutes ago
S&P 500 Forecast: SPX falls after hot inflation and as AI debt concerns mount
bloomingbit
·
18 minutes ago
U.S. Stocks Turn Mixed; Nasdaq Falls 0.27%
Breakingthenews.net
·
12 minutes ago
Dow up 500 pts as investors rotate out of tech stocks
TradingView
·
2 hours ago
S&P 500 Health Care ETF (RSPH) Touches New 52-Week High
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV
CEOPaul Stoffels | Paul Stoffels
Employees196
Founded1999
Headquarters-
SectorBiotechnology
Websitelakefrontbio.com